Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH ) (FRESH)
Feraccru® Real World Effectiveness Study in Hospital Practice (FRESH): A Real World Study to Describe the Outcomes Associated With the Use of Ferric Maltol (Feraccru) for the Management of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease in the UK.
Sponsor: Shield Therapeutics
A observational or N/A phase clinical study on Anemia, Iron Deficiency and Inflammatory Bowel Diseases, this trial is completed. The trial is conducted by Shield Therapeutics and has accumulated 11 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Oct 2020 — Nov 2020 [monthly]
Completed
-
Dec 2019 — Oct 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2018 — Dec 2019 [monthly]
Active Not Recruiting
Status: Not Yet Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shield Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .